Головна / Новини / WHO Medical Product Alert N°5/2020 related to falsified “Defibrotide” identified in Australia, Latvia and Saudi Arabia

WHO Medical Product Alert N°5/2020 related to falsified “Defibrotide” identified in Australia, Latvia and Saudi Arabia

Опубліковано 20.05.2020 о 19:02

The State Service of Ukraine on Medicines and Drugs Control has received the information regarding falsified DEFIBROTIDE 200MG VIALS OF 2.5ML (80MG/ML) CONCENTRATE FOR SOLUTION FOR INFUSION identified in Australia, Latvia and Saudi Arabia.

More detailed information can be found via WHO website:   

https://www.who.int/medicines/publications/drugalerts/  

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

Recognition of documents issued by the regulatory authorities of the European Economic Area countries and Great Britain regarding medicinal products manufacture

Наступна

The State Pharmacopoeia of Ukraine (SPhU) Supplement 4 is coming into force